BioSpace News Archive

GO2 Foundation for Lung Cancer announced it will celebrate Genentech with the “Simply the Best Award” at its XV Virtual Annual Simply the Best Gala on November 14, 2020 at 6:30 pm PT.

Fewer New Yorkers are dying from the coronavirus than health experts had anticipated, a new study shows.

Asana BioSciences, a clinical stage biopharmaceutical company, announced that ASN007 clinical data on safety, efficacy and pharmacokinetics in solid tumor patients will be presented at the 32nd EORTC-NCI-AACR Virtual Symposium on Molecular Targets and Cancer Therapeutics to be held on October 24-25, 2020.

Pfizer to develop ARX-1796 which, if approved, has potential to be the first novel oral beta-lactamase inhibitor + antibiotic combination in more than 35 years

Replimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced the pricing of its public offering of 4,687,500 shares of its common stock at a public offering price of $40.00 per share.

Round led by PureosBioventures with new and existing investors, London-based 4BIO Capital, btov Partners, Redalpine, VI Partners and Schroder Adveq

Swedish Orphan Biovitrum AB announces its results for the third quarter 2020.

CohereNext® Platform, co-designed with physicians, enables health plans and physicians to align on patient care journeys, driving improved quality and safety

Synlogic, Inc., a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced that it will present a poster on SYNB8802, an investigational Synthetic Biotic medicine for the treatment of Enteric Hyperoxaluria, during the American Society of Nephrology Kidney Week, Oct. 22-25, 2020.

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced that Jeff Jonas, M.D., chief executive officer, will undergo a scheduled surgical procedure